CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the role of gut microbiota in the effectiveness of depression treatments, particularly focusing on patients who do not respond to Selective Serotonin Reuptake Inhibitors. By analyzing gut bacteria profiles and their interactions with antidepressants, the goal is to develop a probiotic product…
This interdisciplinary project aims to improve response to depression treatment using the gut microbiota.
About one third of patients with depression do not respond to treatment with Selective-Serotonin-Reuptake-Inhibitors (SSRIs).
Moreover, side effects such as gastrointestinal complaints are common.
The commensal gut microbiota, residing in the human intestinal tract in trillions, likely contribute to variation in treatment efficacy.
This makes them a promising candidate to improve treatment r…
JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
